Process Validation Procedure : Complete GMP Guide

Introduction for Process Validation

Process validation is one of the most important activities in pharmaceutical manufacturing. In an Oral Solid Dosage (OSD) facility, products such as tablets and hard gelatin capsules pass through several manufacturing stages, including dispensing, sifting, granulation, drying, milling, blending, lubrication, compression or encapsulation, coating and packing.

A good process validation procedure provides documented evidence that the manufacturing process can consistently produce a product meeting its predefined quality requirements.

FDA describes three broad stages: Process Design, Process Qualification and Continued Process Verification (CPV).

Related Articles

Computer System Validation – Procedure

Analytical Method Validation

What Is Process Validation?

Process validation is a documented, science-based activity used to demonstrate that a manufacturing process is capable of consistently producing a product that meets predetermined quality attributes and specifications.

For an OSD product, this means demonstrating that the complete manufacturing process—from dispensing through the relevant finished-product stage—operates in a controlled and reproducible manner.

Dispensing → Sifting → Granulation → Drying → Milling → Blending → Lubrication → Compression → Coating → Packing

Process validation should not simply demonstrate that the final tablets pass testing. It should provide evidence that the important manufacturing steps and process parameters are appropriately controlled.

FDA’s lifecycle approach connects process understanding, process qualification and ongoing monitoring rather than treating validation as a one-time exercise.

Why Is Process Validation Required?

The primary purpose of process validation is to provide confidence that the manufacturing process can repeatedly produce acceptable product.

In practical OSD manufacturing, validation helps to:

  • Identify sources of process variation.
  • Establish appropriate process parameters.
  • Confirm equipment and process capability.
  • Demonstrate reproducibility between batches.
  • Confirm that critical quality attributes remain under control.
  • Establish appropriate sampling and monitoring requirements.
  • Reduce the possibility of batch failures.
  • Support regulatory submissions and inspections.
  • Provide a scientific basis for continued process monitoring.
  • Support changes to equipment, materials, batch size or manufacturing parameters.

The important point is that validation is not merely three batches passing final product testing. The manufacturer should understand why the process works and how important sources of variability are controlled.

FDA specifically emphasizes understanding sources of variation, detecting and measuring variation, understanding its effect on product quality and controlling variation according to risk.

Regulatory and GMP Expectations

Several major regulatory and GMP principles influence process validation for OSD products.

FDA Process Validation

The FDA’s Process Validation: General Principles and Practices guidance uses a lifecycle model consisting of:

  1. Stage 1 – Process Design
  2. Stage 2 – Process Qualification
  3. Stage 3 – Continued Process Verification

The objective is to establish scientific evidence that the process is capable of consistently producing quality product.

Importantly, FDA does not prescribe a universal minimum number of validation batches. The manufacturer should establish the number scientifically and provide an appropriate rationale.

ICH Q8, Q9 and Q10

ICH Q8 supports pharmaceutical development and process understanding. ICH Q9 provides the framework for quality risk management, while ICH Q10 describes the pharmaceutical quality system.

Together, these concepts support a science- and risk-based validation strategy.

ICH materials also recognize that risk assessment can help develop validation plans and that statistical monitoring can support continued assurance of process control.

European GMP Expectations

EMA guidance expects the manufacturing process for finished products to be validated before the product is placed on the market, subject to applicable regulatory provisions and exceptional circumstances. It also recognizes traditional process validation, continuous process verification and combinations of these approaches.

Detailed Process Validation Procedure for OSD

A practical process validation program can be divided into the following stages.

Select the Product for Validation

Before preparing the protocol, identify the product to be validated.

The selection should consider:

  • Product dosage form
  • Strength
  • Batch size
  • Manufacturing process
  • Equipment train
  • Manufacturing site
  • Product complexity
  • Previous manufacturing experience
  • Regulatory commitments
  • Existing process knowledge

For products having multiple strengths or batch sizes, a scientifically justified bracketing or matrixing approach may sometimes be appropriate.

The justification should be documented rather than assuming that one validated batch automatically represents every strength and batch size.

Review Product and Process Knowledge

Before validation begins, review the available development and manufacturing information.

Important documents may include:

  • Master Formula Record
  • Batch Manufacturing Record
  • Product development report
  • Technology transfer documents
  • Risk assessments
  • Previous validation studies
  • Scale-up studies
  • Stability information
  • Specifications
  • Analytical method validation
  • Equipment qualification documents
  • Cleaning validation information
  • Change controls
  • Deviations and investigations

This review provides the foundation for determining what needs to be challenged during validation.

Identify CQAs

CQA means Critical Quality Attribute.

A CQA is a physical, chemical, biological or microbiological characteristic that should be within an appropriate limit, range or distribution to ensure product quality.

For an OSD tablet, CQAs may include:

ProductCQA
TabletAssay
TabletContent uniformity
TabletDissolution
TabletRelated substances
TabletHardness
TabletFriability
TabletWeight variation
TabletDisintegration
TabletAppearance
Coated tabletCoating uniformity
CapsuleAssay
CapsuleContent uniformity
CapsuleDissolution
CapsuleWeight variation

Not every attribute will necessarily be a CQA. The designation should be scientifically justified based on product knowledge and risk.

Identify CPPs

CPP means Critical Process Parameter.

These are process parameters whose variability can affect a CQA and therefore need to be appropriately controlled.

Examples in OSD manufacturing include:

Process StepPossible Process Parameters
SiftingScreen size, operating time
GranulationBinder quantity, addition rate, impeller speed
Wet granulationGranulation time, endpoint
DryingInlet temperature, product temperature, drying time
MillingScreen size, mill speed
BlendingBlender speed, blending time
LubricationLubrication time, blender speed
CompressionCompression force, turret speed, feeder speed
CoatingSpray rate, inlet temperature, product temperature
EncapsulationMachine speed, fill-weight settings

These are examples only. The actual CPPs should be established from product and process knowledge and documented risk assessment.

Perform Process Risk Assessment

A risk assessment should be performed before finalizing the validation protocol.

Common tools include:

  • FMEA
  • Fishbone analysis
  • HACCP
  • Risk ranking
  • Process mapping

For example, in a tablet compression process:

High compression force → increased tablet hardness → possible effect on disintegration/dissolution

This relationship should be considered when establishing the control strategy and validation sampling plan.

The purpose of risk assessment is not to create a complicated document. Its purpose is to identify where process variability can have a meaningful impact on product quality.

Prepare the Process Validation Protocol

The protocol should be approved before execution.

A practical protocol should include:

Product Information
  • Product name
  • Strength
  • Dosage form
  • Batch size
  • Manufacturing site
  • Manufacturing equipment
Validation Objective

Clearly state what the study is intended to demonstrate.

Scope

Define the manufacturing steps covered by the validation.

Responsibilities

Clearly assign responsibilities to:

  • Production
  • Quality Assurance
  • Quality Control
  • Engineering
  • Validation
  • R&D or Technology Transfer, where applicable
Process Description

Describe the manufacturing process in sufficient detail.

Critical Parameters

Identify CPPs and their operating ranges.

Critical Quality Attributes

List relevant CQAs and acceptance requirements.

Sampling Plan

Define:

  • Sampling locations
  • Sampling quantity
  • Sampling frequency
  • Sample identification
  • Testing requirements
  • Responsible department
Acceptance Criteria

Predefine acceptance criteria before execution.

Deviations

Define how deviations observed during validation will be documented and evaluated.

Confirm Equipment and Utilities Are Qualified

Process validation should not be used to qualify an unqualified manufacturing system.

Before execution, confirm that relevant:

  • Manufacturing equipment
  • Utilities
  • Instruments
  • HVAC systems
  • Weighing systems
  • Temperature monitoring systems
  • Compressed air systems
  • Water systems
  • Computerized systems

are appropriately qualified or otherwise demonstrated to be suitable for their intended use.

ICH implementation materials specifically emphasize that facilities, equipment and relevant computerized systems should be suitably qualified and personnel appropriately trained.

Verify Analytical Methods

The tests used to evaluate validation samples should be performed using approved and appropriately validated or otherwise qualified analytical procedures, as applicable.

For an OSD process validation study, QC may test:

  • Description
  • Identification
  • Assay
  • Content uniformity
  • Dissolution
  • Related substances
  • Water/moisture
  • Disintegration
  • Hardness
  • Friability
  • Microbial quality, where applicable

The testing plan should be scientifically linked to the product and process risks.

Manufacture Validation Batches

Validation batches should be manufactured using the intended commercial manufacturing process and appropriately representative conditions.

Production personnel should follow the approved manufacturing procedure.

Important information should be recorded during execution, including:

  • Material quantities
  • Equipment identification
  • Equipment settings
  • Environmental conditions where relevant
  • Process parameters
  • Start and end times
  • In-process test results
  • Yield
  • Sampling activities
  • Deviations
  • Interventions
  • Equipment alarms
  • Any unusual observations

The goal is to demonstrate the actual manufacturing process—not an artificially simplified laboratory version of it.

Perform Enhanced Sampling During Validation

Validation normally involves more detailed monitoring than routine manufacturing.

For example, during blending, samples may be taken from multiple locations to evaluate blend uniformity.

During compression, samples may be collected at:

  • Beginning
  • Middle
  • End

Additional samples may be taken when justified by risk.

For coating, monitoring may include:

  • Weight gain
  • Appearance
  • Coating parameters
  • Product temperature
  • Spray rate
  • Inlet/outlet conditions

The sampling plan should be designed to detect potential variability rather than simply generate a large number of samples.

Evaluation In-Process Results

In-process results should be reviewed against predetermined requirements.

Examples include:

  • Blend uniformity
  • Granule moisture
  • Granule particle size
  • Tablet weight
  • Tablet hardness
  • Thickness
  • Friability
  • Compression force
  • Coating weight gain

Trending is particularly useful because a process can technically remain within specification while showing an undesirable trend.

Evaluation of Finished Product Results

Each validation batch should be evaluated against the approved finished-product specifications.

Typical tests for tablets may include:

  • Description
  • Identification
  • Assay
  • Uniformity of dosage units
  • Dissolution
  • Related substances
  • Disintegration
  • Friability, where applicable

For capsules, the testing strategy should be appropriate to the dosage form and product.

All results should be scientifically reviewed rather than considering only whether the final specification was passed.

Evaluate Yield and Material Reconciliation

Yield is an important process performance indicator.

Evaluate:

  • Theoretical yield
  • Actual yield
  • Percentage yield
  • Stage-wise yield
  • Material reconciliation
  • Rejects
  • Process losses

Unexpected changes in yield can sometimes indicate process problems even when the finished product meets specifications.

Compile and Approve the Validation Report

After completion of the validation batches, prepare a validation report.

The report should summarize:

  • Objective
  • Scope
  • Protocol reference
  • Batch details
  • Manufacturing equipment
  • Process parameters
  • Sampling results
  • In-process results
  • Finished-product results
  • Yield
  • Deviations
  • Investigations
  • Statistical analysis
  • Trend evaluation
  • Acceptance criteria assessment
  • Conclusion

The final conclusion should clearly state whether the process has demonstrated an acceptable level of control.

FDA’s validation principles emphasize objective data and evidence demonstrating reproducibility rather than simply relying on assumptions.

PV Practical Implementation in Plant

A simple way to visualize the implementation is:

Product Development

Process Understanding

Risk Assessment

Identify CQAs & CPPs

Validation Protocol

Equipment/Utility Qualification

Validation Batch Manufacturing

Enhanced Sampling & Testing

Data Analysis

Deviation Evaluation

Validation Report

QA Approval

Continued Process Verification

This approach makes process validation a controlled activity rather than a paperwork exercise.

Acceptance Criteria

Acceptance criteria should be established before validation begins.

They should be scientifically justified and linked to the product, process and applicable specifications.

For example:

ParameterExample Acceptance Criteria
AssayWithin approved product specification
DissolutionMeets approved specification
Blend uniformityMeets predefined criteria
Granule moistureWithin established process range
Tablet weightWithin approved in-process limits
Tablet hardnessWithin established range
FriabilityWithin approved requirement
Coating weight gainWithin predefined target/range
YieldWithin established validated range
CPPsWithin approved operating/validation range

A validation protocol should not be written in a way that allows the acceptance criteria to be decided after seeing the results.

Common Mistakes in during Process Validation

Focusing Only on Finished Product Testing

Passing final product testing does not automatically prove that the manufacturing process is well controlled.

The process itself must be understood and evaluated.

Poor Sampling Strategy

Taking samples without considering process risk can result in a large amount of data that provides little useful information.

Using Unqualified Equipment

Validation performed on equipment that has not been appropriately qualified creates a major weakness in the validation program.

Changing Parameters During Validation Without Assessment

Changes to important process parameters during validation should be properly documented and scientifically assessed.

Process Validation Documentation

A robust OSD process validation package may contain the following:

DocumentPurpose
Validation Master PlanDefines overall validation strategy
Process Risk AssessmentIdentifies process risks
Process Validation ProtocolDefines how validation will be performed
Approved MFR/BMRDefines manufacturing process
Equipment QualificationConfirms equipment suitability
Calibration RecordsConfirms measurement reliability
Training RecordsConfirms personnel qualification
Sampling PlanDefines validation sampling
Analytical ResultsProvides quality evidence
In-Process ResultsDemonstrates process control
Finished Product ResultsConfirms product quality
Investigation/CAPAAddresses significant issues
Process Validation ReportSummarizes study conclusions

Manufacturing Process in Process Validation

Dispensing → Sifting → Wet Granulation → Drying → Milling → Blending → Lubrication → Compression → Packing

Potential CQAs during Process Validation

  • Assay
  • Content uniformity
  • Dissolution
  • Related substances
  • Tablet weight
  • Hardness
  • Friability
  • Disintegration

Potential CPPs during Process Validation

ProcessPotential CPP
GranulationImpeller speed
GranulationBinder addition rate
GranulationGranulation time
DryingProduct temperature
DryingMoisture endpoint
MillingScreen size
BlendingBlending time
LubricationLubrication time
CompressionCompression force
CompressionMachine speed
CoatingSpray rate
CoatingProduct temperature

The actual CPP designation should be based on product/process understanding and risk assessment, not simply because a parameter appears on the machine.

FAQs for Process Validation

What is process validation in pharmaceutical manufacturing?

Process validation is the documented demonstration that a manufacturing process can consistently produce a quality product.

Is process validation mandatory for products?

Yes, Process validation is mandatory for each and every products. Manufacturers are expected to demonstrate that their commercial manufacturing processes are capable of consistently producing acceptable quality products.

How many batches are required for process validation?

There is no universal FDA requirement that every product must have exactly three validation batches. The number should be scientifically justified based on process knowledge, complexity and risk.

What are CPP and CQA?

CPP means Critical Process Parameter, while CQA means Critical Quality Attribute. CPPs relate to process variables that can affect product quality, while CQAs are product characteristics important for ensuring the required quality.

What is the difference between PPQ and process validation?

Process Performance Qualification (PPQ) is an important part of the process validation lifecycle, particularly in the qualification stage. Process validation is broader and encompasses lifecycle activities from process design through ongoing verification.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top